Completion of Whole Blood Assets Sale to GVS Likely to Boost HAE Stock

Haemonetics (HAE) recently completed the sale of its whole blood assets to GVS, S.p.A ("GVS"), a leading provider of advanced filtration solutions for highly critical applications. With this development, GVS now has the company’s portfolio of proprietary whole blood collection, processing and filtration solutions, along with its manufacturing facility in Covina, CA and related equipment and assets at its Tijuana, Mexico manufacturing site.The transaction was announced last month and comprises a total cash c ...